We first analyzed the transcription regulators histone H3 and c-MYC because we found heterogeneous global transcription inhibition in AZD1208-treated CLL samples (Figure 3A and 3C). The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.